Credit Suisse Cap. Willis Towers Watson - Form 38.5(b) - Willis Towers Watson plc

S1

15/06/2021 12:04

RNS Number : 9679B

Credit Suisse Capital LLC

15 June 2021

 

Ap27

 

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED 

INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.          KEY INFORMATION

 

Nameofexemptprincipaltrader
Credit Suisse Capital LLC
Companydealtin
Willis Towers Watson Plc
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note1)
Ordinary
Dateofdealing
14th June 2021


 

2.          INTERESTS AND SHORT POSITIONS

 

(a)         Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 

Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
209,618 0.15
183,700 0.20
(2)Derivatives(otherthanoptions)
(3)Optionsandagreementstopurchase/sell
Total
209,618 0.15
183,700 0.20


 

 

(b)         Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

 

Classofrelevantsecurity: Swap
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
(2)Derivatives(otherthanoptions)
0 0
199,778 0.14
(3)Optionsandagreementstopurchase/sell
Total
0 0
199,778 0.14


Ap28

 

 

3.       DEALINGS (Note 3)

 

(a)      Purchases and sales

 

Purchase/sale
Numberofrelevantsecurities
Priceperunit (USD)
B
49
256.12
B
1
256.12
B
1
256.12
S
1
256.12

 

(b)      Derivatives transactions (other than options transactions)

 

Productname,
e.g.CFD
Natureoftransaction
(Note5)
Numberofrelevantsecurities
(Note6)
Priceperunit
(Note4) (USD)


 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Productname,
e.g.calloption
Writing,selling,purchasing,varyingetc.
Numberofsecurities towhichtheoptionrelates(Note7)
Exercise price
Type,e.g.American,Europeanetc.
Expiry date
Optionmoney paid/receivedperunit(Note4)


 

 

(ii)      Exercising

 

Productname,
e.g.calloption
Numberofsecurities
Exercisepriceper unit(Note4)


 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 3)

 

Natureoftransaction
(Note7)
Details
Priceperunit
(if applicable) (Note 4)


Ap29

 

4.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached? (Note 8)                    NO

 

 

Dateofdisclosure
15th June 2021
Contactname
Anthony Allen / Paul MacDonald
Telephonenumber
0207 888 5416 / 8548
Nameofofferee/offerorwithwhichconnected
Aon plc
Natureofconnection(Note9)
Advisor to Aon plc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
ISEGPUWUQUPGGGA